NESSATREN Trademark

Trademark Overview

On Thursday, February 12, 2009, a trademark application was filed for NESSATREN with the United States Patent and Trademark Office. The USPTO has given the NESSATREN trademark a serial number of 77669459. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 8, 2012. This trademark is owned by Glaxo Group Limited. The NESSATREN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines
nessatren

General Information

Serial Number77669459
Word MarkNESSATREN
Filing DateThursday, February 12, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 8, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 16, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 17, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, October 9, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 8, 2012ABANDONMENT - NO USE STATEMENT FILED
Friday, March 2, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 1, 2012EXTENSION 5 GRANTED
Tuesday, February 28, 2012EXTENSION 5 FILED
Tuesday, February 28, 2012TEAS EXTENSION RECEIVED
Wednesday, August 10, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 9, 2011EXTENSION 4 GRANTED
Wednesday, August 3, 2011EXTENSION 4 FILED
Wednesday, August 3, 2011TEAS EXTENSION RECEIVED
Tuesday, February 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 14, 2011EXTENSION 3 GRANTED
Thursday, February 10, 2011EXTENSION 3 FILED
Thursday, February 10, 2011TEAS EXTENSION RECEIVED
Wednesday, September 8, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 7, 2010EXTENSION 2 GRANTED
Thursday, August 12, 2010EXTENSION 2 FILED
Tuesday, September 7, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 12, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 15, 2010EXTENSION 1 GRANTED
Monday, February 15, 2010EXTENSION 1 FILED
Monday, February 15, 2010TEAS EXTENSION RECEIVED
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 8, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 6, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 6, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 16, 2009PUBLISHED FOR OPPOSITION
Wednesday, May 27, 2009NOTICE OF PUBLICATION
Thursday, May 14, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 14, 2009ASSIGNED TO LIE
Thursday, May 14, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 14, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, May 14, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 14, 2009EXAMINERS AMENDMENT E-MAILED
Thursday, May 14, 2009EXAMINERS AMENDMENT -WRITTEN
Friday, May 8, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 8, 2009NON-FINAL ACTION E-MAILED
Friday, May 8, 2009NON-FINAL ACTION WRITTEN
Friday, May 1, 2009ASSIGNED TO EXAMINER
Tuesday, February 17, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 17, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

nessatren pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic